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TYMSTR, a putative chemokine receptor selectively expressed in
activated T cells, exhibits HIV-1 coreceptor function
M. Loetscher*, A. Amara†, E. Oberlin†, N. Brass‡, D.F. Legler*, P. Loetscher*, 
M. D’Apuzzo*, E. Meese‡, D. Rousset†, J-L. Virelizier†, M. Baggiolini*, 
F. Arenzana-Seisdedos† and B. Moser*
Background: Chemokines bind to specific receptors and mediate leukocyte
migration to sites of inflammation. Recently, some chemokine receptors, notably
CXCR4 and CCR5, have been shown to be essential fusion factors on target
cells for infection by human immunodeficiency virus (HIV); the chemokines
bound by these receptors have also been shown to act as potent inhibitors of
HIV infection. Here, we describe the isolation of a novel, putative chemokine
receptor.
Results: We have isolated the cDNA for a putative human chemokine receptor,
which we have termed TYMSTR (T-lymphocyte-expressed seven-
transmembrane domain receptor). The TYMSTR gene is localized to human
chromosome 3 and encodes a protein that has a high level of identity with
chemokine receptors. TYMSTR mRNA was selectively expressed in interleukin-
2-stimulated T lymphocytes but not in freshly isolated lymphocytes and
leukocytes or related cell lines. The natural ligand for TYMSTR was not
identified among 32 human chemokines and other potential ligands. Cells co-
expressing TYMSTR and human CD4 fused with cells expressing envelope
glycoproteins of macrophage (M)-tropic HIV-1 as well as T-cell line (T)-tropic
HIV-1 isolates. Addition of infectious, T-tropic HIV-1 particles to TYMSTR/CD4-
expressing cells resulted in viral entry and proviral DNA formation.
Conclusions: Our findings demonstrate that TYMSTR, in combination with CD4,
mediates HIV-1 fusion and entry. The high-level expression of TYMSTR in CD4+
T lymphocytes and the selectivity of this receptor for T-tropic and M-tropic HIV-1
strains indicates that TYMSTR might function as HIV coreceptor at both early
and late stages of infection.
Background
Chemokines are essential mediators of the recruitment of
leukocytes and lymphocytes to sites of inflammation [1–3]
and are small inducible proteins of 68–103 amino acids
containing four conserved cysteine residues. The arrange-
ment of the first two cysteines defines the two subfamilies
of CXC and CC chemokines. Chemokines act on all types
of immune cells, including monocytes/macrophages, den-
dritic cells, granulocytes, natural killer cells and lympho-
cytes, and induce migration, increased adhesion and
various immune defense functions. These target cells
express chemokine receptors, which belong to the large
family of G-protein-coupled, seven-transmembrane
domain receptors [1,4,5]. Currently, 12 human chemokine
receptors are known that are selective either for CXC
chemokines (CXCR1–4) or CC chemokines (CCR1–8). 
It has been known for a long time that CD4 molecules on
host cells interact with the envelope (Env) glycoproteins
on human immunodeficiency virus (HIV) [6–8]; however,
CD4 alone is not able to mediate fusion and viral entry,
which are critical steps in HIV infection, and additional
host factors have been proposed to be involved. Recently,
chemokines and their receptors have been found to play
an important role as fusion cofactors [6–8]. Apparently,
HIV strains, have evolved to recognize different human
chemokine receptors on CD4+ target cells. Notably,
CCR5 is selective for macrophage (M)-tropic HIV-1
strains which predominate at early stages in infected indi-
viduals who lack symptoms of acquired immunodeficiency
syndrome (AIDS) [9–13]. This coreceptor is expressed on
interleukin-2 (IL-2)-treated CD45RO+ T cells, which
could be a primary host for HIV replication in infected
individuals. Two additional CC chemokine receptors,
CCR2 and CCR3, show a similar specificity [12,13]. By
contrast, CXCR4 is the coreceptor for T-cell line (T)-
tropic, syncytia-inducing HIV-1 strains, which are promi-
nent in patients with AIDS [14]. The specificity for the
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different chemokine receptors is determined by variable
regions in the HIV-1 envelope glycoprotein (Env),
whereas the constant regions in Env bind to CD4 [15,16].
The interaction of target cells with HIV Env glycoproteins
leads to binding, fusion and viral entry. In addition,
chemokines that bind to the coreceptors —  RANTES
and the macrophage inflammatory proteins MIP-1α and
MIP-1β for CCR5, and the stromal-cell-derived factor
SDF-1 for CXCR4 — block HIV-1 entry in vitro [17–19].
In a search for chemokine receptors that are selectively
expressed on T lymphocytes in inflammation and disease,
we have isolated the cDNA for a novel, putative
chemokine receptor, termed TYMSTR for T-lymphocyte-
expressed seven-transmembrane domain receptor.
TYMSTR is selectively expressed in activated T lympho-
cytes and related cell lines but not in peripheral blood
cells, and thus is a good candidate receptor for the regula-
tion of the lymphocyte infiltrate typically seen in delayed-
type immune responses. In combination with CD4,
TYMSTR mediated fusion between cells expressing Env
of T-tropic as well as M-tropic HIV-1 strains. Because of
the selectivity of TYMSTR for certain HIV-1 strains and
the restricted expression of this receptor in activated T
cells, we conclude that TYMSTR represents a novel HIV
coreceptor that may be important in disease progression.
Results
Cloning of TYMSTR cDNA
In contrast to monocytes and granulocytes, the regulation
of T lymphocyte recruitment to sites of inflammation
and disease is not well understood. In order to search for
chemokine receptors that are selectively expressed in T
lymphocytes, we used a PCR-based strategy using
degenerate oligonucleotide primers corresponding to
chemokine receptor motifs [20]. One amplified DNA frag-
ment, MLRB, with nucleotide similarity to known
chemokine receptors hybridized selectively to RNA from
activated but not freshly isolated peripheral blood lym-
phocytes. Using MLRB as hybridization probe, two
cDNAs, TYMSTR1 of 2407 bp and TYMSTR2 of
1973 bp, were isolated from a CD4+ T cell cDNA library;
these cDNAs shared identical coding and 3′ sequences
but differed in the 5′ untranslated regions. Divergency in
the 5′ regions (494 bp and 60 bp in TYMSTR1 and
TYMSTR2, respectively) was due to alternative mRNA
splicing. TYMSTR2 (EMBL Database, accession number
Y13248) corresponds to the completely spliced mRNA,
whereas the 5′ region in TYMSTR1 contains an intron
sequence, as assessed by PCR analysis using genomic
DNA or cDNA as template and by northern blot analysis
(data not shown). The flanking regions of the putative
start codon AUG of the longest open reading frame
conform well to the consensus sequence criteria for trans-
lation initiation in vertebrates [21]. The 3′ untranslated
region contains a single polyadenylation signal sequence,
and ends with a polyA tract. 
The open reading frame of 1026 bp encodes a polypeptide
of 342 amino acids with a molecular weight of 39,280 Da
and we have termed this protein TYMSTR (Figure 1). The
amino-terminal, extracellular region is rich in acidic amino
acids with a net charge of –7, which is typical for chemokine
receptors, and contains a single potential N-linked glycosy-
lation site (Asn16–Asp–Ser). Protein kinase C substrate
motifs (S/TXR/K in single-letter amino-acid code) and 11
serine/threonine residues are found in the third intracellular
loop and the carboxyl terminus and phosphorylation at
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Figure 1
Amino-acid sequence alignment of TYMSTR with the chemokine
receptors CXCR2 and CCR1. Filled boxes with white letters highlight
regions of sequence identity, and boxes with black letters designate
residues in TYMSTR that are shared with either CXCR2 or CCR1; the
putative transmembrane domains (TM 1–TM 7) are also indicated.
these sites might be involved in receptor desensitization.
Searches of known protein sequences revealed that
TYMSTR is most closely related to chemokine receptors
(33–36% sequence identity) and specifically has the highest
level of identity with the type 2 IL-8 receptor, CXCR2, and
the RANTES/MIP-1α receptor, CCR1 (Figure 1).
Expression of TYMSTR
The CD4+ T cell line KT30 that was used to prepare the
cDNA library expressed a TYMSTR mRNA species of
approximately 2 kb, indicating that the TYMSTR2 clone is
complete (Figure 2a). Strong hybridization signals were
also obtained with RNA from the CD8+ T cell line
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(a) (b)
TYMSTR transcript expression in human leukocytes and lymphocytes.
(a) Northern blot analysis was carried out with 10 µg total RNA from
freshly isolated or cultured leukocytes and lymphocytes: PBL,
peripheral blood lymphocytes; PBL (+ IL-2), IL-2-stimulated PBL; PTC,
nylon-wool-purified T cells; ERCD8, CD8+ T-cell line; ERNK57, natural
killer cell line; KT30, CD4+ T-cell line; CD4+ and CD8+ T cells were
purified from fresh PBL. TYMSTR DNA was used as hybridizing probe
(see Materials and methods). Lower panel, ethidium bromide staining
of ribosomal RNA in the gel prior to transfer. (b) TYMSTR transcript
expression in IL-2-stimulated T cell cultures. Freshly isolated PBLs
were cultured in the presence of IL-2 for the number of days indicated
and total RNA was analyzed by northern blot analysis. Lower panel,
ethidium-bromide-stained ribosomal RNA prior to transfer.
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Southern blot analysis and chromosomal localization of the TYMSTR
gene. (a) Southern blot analysis. Genomic DNA from human PBL (10µg
per lane) was digested with BclI, EcoRI, HindIII or SacI, and the blot was
hybridized with the same radiolabeled probe as used for the northern
blot analysis in Figure 2. DNA fragments of 13 kb, 10.5 kb, 9 kb and
5.5 kb were detected and marker DNA fragments are indicated in kb. 
(b) Chromosomal localization of the TYMSTR gene by PCR. DNA from
somatic cell hybrids containing single or multiple human chromosomes
was amplified using specific primers for TYMSTR (see Materials and
methods). Lanes 1–4, cell hybrids containing multiple human
chromosomes (NA09930A, NA09932, NA09935A, NA09937); lanes
5–7, cell hybrids containing human chromosomes 3, 14 and 18,
respectively (NA10253, NA10479, NA11010); lanes 8–10, parental
human, hamster and mouse cell lines, respectively (NAIMR91,
NA10658, NA05862); lane 11, TYMSTR cDNA; lane 12, no template
DNA added; lane 13, DNA molecular weight markers.
ERCD8 and the natural killer cell line ERNK57.
TYMSTR is highly expressed in peripheral blood lympho-
cytes (PBLs), CD4+ and CD8+ T cells after culturing these
cells in the presence of IL-2, which leads to expansion of T
cells with CD45RO+ phenotype [22]. By contrast, unstimu-
lated PBLs, CD4+ and CD8+ T cells did not contain
TYMSTR transcripts. Importantly, TYMSTR transcripts
were not expressed in other types of leukocytes, including
neutrophils, monocytes, cultured macrophages, basophilic
leukemia cells, monocyte-derived dentritic cells and many
other related cell lines. Figure 2b illustrates the kinetics of
TYMSTR expression in PBLs cultured in the presence of
IL-2. The effect of IL-2 became evident after 3 days of
culture and maximal level of TYMSTR expression was
reached at day 6 and maintained up to day 17. 
Chromosomal localization of the TYMSTR gene
TYMSTR is encoded by a single-copy gene, as demon-
strated by Southern blot analysis with fractionated human
genomic DNA (Figure 3a). Chromosomal localization of the
TYMSTR gene was performed by PCR using TYMSTR-
specific primers (see Materials and methods). As shown in
Figure 3b, PCR products of the correct size were found in
the three independently derived multiple chromosome-
containing somatic cell hybrids that had human chromo-
somes 3, 14 and 18 in common (lanes 1, 3 and 4). Using cell
hybrids that harbor single human chromosomes, the gene
for TYMSTR could be assigned to human chromosome 3
(lane 5), coinciding with the chromosomal localization of
the genes for all known CC chemokine receptors [23]. 
Chemokine selectivity of TYMSTR
In order to screen for ligands that interact with TYMSTR,
murine pre-B cells (300-19) were stably transfected with
TYMSTR cDNA, and clones that expressed high levels of
TYMSTR transcripts were selected (data not shown). The
agonists listed in Table 1, including 9 CXC chemokines
and 17 CC chemokines, and unrelated ligands that bind to
leukocyte G-protein-coupled receptors were tested for their
activity in transfected 300-19 cells expressing TYMSTR. In
addition, the C and CX3C chemokines and four novel,
unpublished chemokines have been tested. However, none
of these substances induced [Ca2+]i mobilization and in vitro
chemotaxis, two typical chemokine-induced leukocyte
responses. As a positive control, clones of 300-19 cells
expressing CXCR3 responded strongly to the selective
chemokines interferon-γ-inducible protein (IP10) and
monokine induced by interferon-γ (Mig) [20], and parental
300-19 cells, which constitutively express murine CXCR4,
responded to the CXCR4 ligand SDF-1 (data not shown). 
TYMSTR is a coreceptor for HIV-1
The similarity of TYMSTR to chemokine receptors and
its prominent expression in activated CD4+ T cells
prompted us to test this receptor for HIV coreceptor
activity in Env-mediated cell fusion. For this purpose,
NIH3T3 murine fibroblasts were cotransfected with
recombinant plasmids encoding human CD4, a HIV-1
LTR-driven luciferase reporter gene and human
chemokine receptors (CXCR4, CCR5) or TYMSTR.
HEK293 human embryo kidney cells expressing proviral
DNA from T-tropic or M-tropic HIV-1 particles were
used as fusion partners. Cell fusion, occurring after
binding of CD4 and coreceptors to HIV-1 Env glycopro-
teins, was quantified by measuring the luciferase activity
present in the cell lysate. As shown in Figure 4, back-
ground luciferase activity was very low; background activ-
ity was assayed on parental HEK293 cells mixed with
CD4+, luciferase-positive NIH3T3 cells that were trans-
fected with TYMSTR cDNA or plasmid alone. A 14-fold
increase in luciferase activity was obtained, however,
when NIH3T3 cells expressing TYMSTR were co-
cultured with HEK293 cells expressing Env of the M-
tropic HIV-1 YU2, but TYMSTR did not recognize the
Env glycoprotein of the M-tropic HIV-1 JR-CSF.
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Table 1
Ligands tested for [Ca2+]i mobilization and chemotaxis
Agonist [Ca2+]i* Chemotaxis† Control‡
RANTES – – Monocytes
MCP-1 – – Monocytes
MCP-2 – – Monocytes
MCP-3 – – Monocytes
MCP-4 – – Monocytes
Eotaxin – – Eosinophils
Eotaxin-2 – – Eosinophils
MIP-1α – – Monocytes
MIP-1β – – Monocytes
I-309 – – n.d.§
HCC-1 – – Monocytes
TARC – – T cells
LARC – – n.d.
ELC – – n.d.
MIP-4 – – n.d.
MDC – – CEM
CKβ8 – – Monocytes
IL-8 – – Neutrophils
GROα – – Neutrophils
NAP-2 – – Neutrophils
GCP-2 – – Neutrophils
ENA-78 – – Neutrophils
Mig – – T cells
IP-10 – – T cells
SDF-1 – – Monocytes
PF4 – – n.d.
C3a – – HMC-1
C5a – – Neutrophils
LTB4 – – Neutrophils
Calcitonin – – n.d.
NPY – – SK-N-MC
Somatostatin – – n.d.
Substance P – – HMC-1
The ligands were tested in clones of 300-19 cells that stably
expressed TYMSTR. *[Ca2+ ]i responses to 100 nM agonist were
measured in Fura2/acetoxymethylester-loaded cells. †Chemotaxis in
vitro was analyzed with chemokine in the range 1 nM to 1 µM. ‡The
cells listed were used as positive control for the activity of the
corresponding agonists. §n.d., not determined.
TYMSTR also functioned as a fusion receptor for the T-
tropic viral clone pNL4-3, which carries the Env gene of
the HIV-1 Lai.
Recognition of Env of HIV-1 Lai by TYMSTR was
further documented in an alternative cell-fusion assay.
NIH3T3 cells co-expressing human CD4 and TYMSTR
or human CD4 and either CXCR4 or CCR5 as well as the
HIV-1 LTR-driven lacZ gene were co-cultured for fusion
with HeLa cells expressing Env(Lai) or Env of HIV-1
ADA. As revealed by intracellular staining for β-galactosi-
dase activity, TYMSTR recognized Env(Lai) and fusion
resulted in multinucleated cells (Figure 5). In contrast,
TYMSTR failed to support fusion with HeLa cells
expressing Env(ADA). As positive controls, CXCR4 medi-
ated fusion with cells expressing the T-tropic Env(Lai),
and CCR5 was active with cells expressing the M-tropic
Env(ADA). Parental HeLa(∆Env) cells lacking viral Env
glycoproteins were used as negative control and did not
show any fusion activity.
Infection of TYMSTR-expressing cells by T-tropic HIV-1
particles
An early post-fusion event during viral infection is the for-
mation of proviral DNA by the HIV-1 reverse transcrip-
tase. This is required for expression of genes encoding
viral proteins and, ultimately, for the generation of new
infectious particles. Murine 300-19 cells expressing
656 Current Biology, Vol 7 No 9
Figure 4
TYMSTR mediates fusion with HEK293 cells expressing HIV-1
Env(YU2) and Env(Lai). NIH3T3 cells were transfected with a plasmid
containing HIV-1 long terminal repeat (LTR)-driven luciferase reporter
gene and plasmid DNA encoding human CD4 and either TYMSTR or
other coreceptors (CXCR4, CCR5). These cells were mixed with
HEK293 cells transfected with DNA for various molecular clones of
HIV-1, and fusion was quantified by measuring luciferase activity
(relative units) in the cell lysate. As a negative control, fusion partner
cells [CD4+ NIH3T3(lucif), HEK293] were transfected with empty
plasmid vector DNA.
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Figure 5
TYMSTR mediates syncytia formation with
HeLa cells expressing Env(Lai). NIH3T3 cells
transfected with a HIV-1 LTR-driven 
β-galactosidase reporter gene and plasmids
encoding human CD4 together with TYMSTR
or other coreceptors (CXCR4, CCR5) were
mixed with HeLa cells expressing the viral Env
glycoproteins of HIV-1 Lai or HIV-1 ADA, and
cell fusion was monitored by staining for
intracellular β-galactosidase activity. The
negative control monitored fusion between
HeLa(∆Env) cells and NIH3T3 cells
cotransfected with reporter gene DNA, CD4
DNA and empty vector DNA.
∆Env Lai ADA
pcDNA3
CXCR4
CCR5
TYMSTR
TYMSTR together with human CD4 became infected
with T-tropic HIV-1 Lai particles, as assayed by PCR
detection of proviral DNA (Figure 6). Formation of provi-
ral DNA was inhibited by the reverse transcriptase
inhibitor AZT, indicating that the amplified DNA derived
from newly reverse-transcribed HIV-1 Lai RNA. The
chemokine SDF-1, which has been shown to block
CXCR4-mediated infection by T-tropic HIV-1 strains
[18,19], did not prevent proviral DNA formation, and
300–19 cells expressing human CD4 alone were not
infected, demonstrating that viral entry was mediated by
TYMSTR in combination with CD4. The weak AZT-
insensitive amplification signals observed in all lanes were
probably due to HIV-1 Lai-associated proviral DNA
present from input virus. Our findings from cell fusion and
viral entry assays demonstrate that TYMSTR has CD4-
dependent HIV coreceptor function.
Discussion
Several features suggest that TYMSTR is a novel
chemokine receptor. Firstly, TYMSTR has highest amino
acid sequence identity (33–36%) with CXC and CC
chemokine receptors whereas it has <30% similarity with
other G-protein-coupled receptors, such as the receptors
for the non-chemokine attractants fMet–Leu–Phe, ana-
phylatoxins C5a and C3a, the lipid mediator platelet-acti-
vating factor, and the thrombin receptor [24–28]. In
addition, chemokine receptors are similar in size, ranging
from 350–368 amino acids, which agrees well with the size
of TYMSTR; most other G-protein-coupled receptors are
over 400 amino acids in size [4,5,29].
Secondly, 25% of the amino acids in the extracellular
amino-terminal region in TYMSTR are charged, having
an eight-fold excess of acidic residues, which is typical for
chemokine receptors [1,4,5,29]. The corresponding
regions in the IL-8 receptors CXCR1 and CXCR2, for
example, are composed of 22% and 26% charged residues
with a nine-fold and six-fold excess of acidic residues,
respectively [30,31]. These parts of the receptors have
been shown to be essential for binding of chemokines,
which themselves are highly charged and basic [32–34]. 
Thirdly, using a PCR-based method we could assign the
TYMSTR gene to the human chromosome 3, the same
chromosomal location of the genes for all five CC
chemokine receptors [23], suggesting that the natural
ligand for TYMSTR might be a CC chemokine. By con-
trast, the genes for the three CXC chemokine receptors
CXCR1, CXCR2 and CXCR4 are localized to human
chromosome 2 [35–37]. 
The selective expression of TYMSTR in activated T cells
is notable with regard to its potential role in T-cell
recruitment as well as HIV infection [38]. IL-2 treatment
of PBLs or purified T cells induced prominent expression
of TYMSTR, whereas non-activated T cells and any other
type of leukocytes lacked detectable levels of TYMSTR
transcripts. It is important to note that triggering of the T-
cell receptor by means of immobilized anti-CD3, either
alone or in combination with anti-CD28, or T-cell activa-
tion by phytohemagglutinin did not induce TYMSTR
expression. These findings suggest that TYMSTR is
involved in the selective recruitment of IL-2-expanded
immunocompetent T cells to sites of inflammation. 
For fusion and cell entry, HIV requires two key molecules
on target cells, CD4 and an appropriate coreceptor [6,7].
CD4 is present on a subset of T cells thought to be the
primary host cells for viral replication, and on certain
antigen-presenting cells. By contrast, coreceptors belong to
the growing family of chemokine receptors, which differ in
their selectivity for chemokines and, equally important, in
their range of cellular expression. Most chemokine recep-
tors are present in large numbers in monocytes and granu-
locytes but not in circulating T lymphocytes [1–5]. In order
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Figure 6
Entry of HIV-1 Lai in murine 300-19 cells
transfected with TYMSTR and CD4. Clones of
300-19 cells that stably expressed human CD4
either alone or in combination with TYMSTR
were infected with infectious HIV-1 Lai
particles in the absence (–) or presence (+) of
10 µM AZT or 100 nM SDF-1, and newly
formed proviral DNA was detected by PCR as
described in Materials and methods. To
evaluate the sensitivity of the assay, purified
proviral DNA (1–103 copies) and DNA
harvested from 200, 4 × 103 or 105 infected
cells were included in the assay, and amplifi-
cation of β-actin DNA was performed as an
internal control. Amplification products were
separated by polyacrylamide gel electro-
phoresis and visualized by autoradiography.
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to express chemokine receptors, including CCR1, CCR2
and CCR5, and to become responsive to chemokines, T
lymphocytes need to be activated, notably by stimulation
with IL-2, which leads to expansion of CD26+, CD45RO+
T cells [20,22]. TYMSTR is selectively expressed in these
activated cells and functions as an HIV-1 coreceptor. The
lower potency of TYMSTR in cell fusion, compared with
that of CXCR4 and CCR5, might reflect a lower affinity of
TYMSTR for the Env glycoproteins of HIV-1 YU2 and
HIV-1 Lai. It is likely that mutational changes in the HIV
env gene, which occur rapidly during replication in infected
individuals, could generate HIV-1 variants that have a high
affinity for TYMSTR. Identification of such isolates in
vitro might have been hampered by the procedures used
for their amplification. In fact, TYMSTR is not expressed
in phytohemagglutinin-activated peripheral blood
mononuclear cells, which are routinely used as host cells
for the culturing of primary viruses.
Conclusions
TYMSTR transcripts are abundant in activated T lympho-
cytes but are not detectable in resting lymphocytes or
other leukocytes, suggesting that this putative chemokine
receptor and its natural ligand are involved in the recruit-
ment of immunocompetent T lymphocytes in T-cell-
dependent immune responses. In addition, TYMSTR has
HIV coreceptor function: its high-level expression in CD4+
T lymphocytes, together with its ability to interact with
viruses that predominate either at early stages in HIV+
individuals or during disease progression, indicates that
TYMSTR might be involved in HIV-1 infection. For a
detailed understanding of disease progression, it is impor-
tant to identify further HIV coreceptors with prominent
expression in CD4+ cells. This conclusion is consistent
with our own observation (D. Rousset, D. Mathez, E.
Oberlin, J. Leibowitch, F. Arenzana-Seisdedos and J-L.
Virelizier, unpublished observations) that primary isolates
from some patients with AIDS can not be blocked in vitro
by the combined addition of known HIV suppressor
chemokines, suggesting that novel HIV coreceptors are
required. During the review stages of this manuscript,
similar results were reported by Berger and colleagues [39].
Material and methods
Proteins
Chemokines and related proteins were prepared by chemical synthesis
according to established protocols [40]. C3a and C5a were a gift of 
C. A. Dahinden, University Hospital, Bern. Somatostatin, calcitonin and
substance P were from Sigma and LTB4 was donated by J. Rokach,
Merck Frosst Canada Inc.. 
Cell preparation
Neutrophils, monocytes and human PBLs were isolated from donor
blood buffy coats as described [41]. PBL and cloned human T and NK
cells (KT30, ERCD8, ERNK57) were cultured in RPMI-1640 medium
containing 2 mM glutamine, 1 × non-essential amino acids, 1 mM
sodium pyruvate, 100 µg/ml kanamycin, 50 µM 2-mercaptoethanol and
5% human serum in the presence of 400 U/ml human recombinant 
IL-2. Murine 300-19 cells were maintained as described [22].
TYMSTR cDNA cloning
The cloning of TYMSTR cDNA was performed essentially as described
for CXCR3 [20]. For PCR amplification on a Master Cycler 5330
(Eppendorf-Netheler-Hinz), the degenerate primers 5′-GGGCTGCAG
CIIT(T/G)(T/G)C(C/A)GAC(A/C)TICTI(C/T)T-3′ and 5′-GGGTCTA-
GAAA(A/G)GC(A/G)TA(G/C)AI(G/C)AIIGGGT-3′, I is inosine) were
used with human genomic DNA as template. PCR products of the
expected size (600–700 bp) were sequenced and examined for homol-
ogy with known chemokine receptors and expression in leukocytes.
The amplified DNA fragment, MLRB, was used as hybridization probe
for isolation of TYMSTR clones out of a human CD4+ T cell (KT30)
library [20].
Northern and Southern blot analysis
Samples of 10 µg total RNA from human leukocytes and cultured cell
lines (KT30, ERCD8, ERNK57) were analyzed as described [20]. PBL
and fractionated CD8+ and CD4+ T cells were cultured for up to
10 days in the presence of IL-2 (400 U/ml) [22]. A 400 bp EcoRV/PstI
fragment of TYMSTR2 was radiolabeled and used as a probe for
hybridization. The membrane was washed up to a stringency of
0.2 × SSC, 0.1% SDS at 65°C, and analyzed using a PhosphorImager
(Molecular Dynamics). For Southern blot, 10 µg samples of genomic
DNA from human PBL were digested with EcoRI, BclI, SacI and
HindIII, separated and vacuum blotted. The membrane was probed,
washed and analyzed as in northern blot analysis.
Chromosomal localization
For chromosomal localization studies, PCR was performed with the
TYMSTR-specific primers 5′-AAGACTATGGGTTCAGCAGT-3′ and
5′-CCACATATGAGCTTGTCGAG-3′ in a PTC-100 Thermocycler (MY
Research). Genomic DNA from monochromosomal somatic cell
hybrids and somatic cell hybrids harboring human chromosomes was
used as template (Coriell Institute). Cell hybrids containing multiple
human chromosomes (hc) were NA09930A (hc: 2–5,7,8,11–15,17,
18,20–22,X,Y), NA09932 (hc: 4–6,8,10–12,17,19,21), NA09935A
(hc: 3–6,10,12–14,17,18,20–22), and NA09937 (hc: 3,4,6–8,10,12,
14,15,17,18); cell hybrids containing single human chromosomes were
NA10253 (hc: 3), NA10479 (hc: 14), and NA11010 (hc: 18); parental
cell lines were NAIMR91 (human), NA10658 (hamster), and NA05862
(mouse). After initial denaturation at 94°C for 3 min, 25 cycles of ampli-
fication were performed at 94°C for 45 s, at 58°C for 45 s, and at 72°C
for 50 s with a final extension for 10 min at 72°C. Products were visual-
ized by ethidium bromide staining of agarose gels. 
Functional assays in TYMSTR transfectants
For the generation of stable transfectants, 4 × 106 mouse pre-B cells
(300-19) were transfected by electroporation with 20 µg linearized
pcDNA3-TYMSTR plasmid DNA. Stable TYMSTR transfectants were
cloned by limiting dilution in the presence of 1.0 mg/ml G418 (Life
Technologies). G-418-resistant clones were screened for TYMSTR
transcript expression by RNA dot-blot analysis using the same
hybridization probe as for the northern and Southern blots [20].
Changes in the cytosolic free Ca2+ concentration ([Ca2+]i) and cell
migration of murine 300-19 clones expressing TYMSTR were evalu-
ated as described [20,22].
HIV-1 cell fusion assays
Subconfluent cultures of NIH3T3 murine fibroblasts were cotrans-
fected with recombinant plasmids encoding human CD4, a HIV-1 LTR-
driven luciferase reporter gene [42] and human chemokine receptors
(CXCR4, CCR5) or TYMSTR. Coreceptor DNAs were cloned into the
expression plasmid pcDNA3, and empty vector was used as a negative
control. DNA transfections were performed with Lipofectamie (Gibco
BRL) according to the manufacturer’s instructions. After culturing for
24 h, NIH3T3 cells were mixed at a ratio of 1:1 with adherent human
embryo kidney (HEK) 293 cells expressing infectious HIV proviral DNA
of either NL4-3, YU2, or JR-CSF HIV-1 isolates. After co-culture for
24 h, cells were harvested and disrupted and luciferase activity was
measured using a luminometer (Berthold). The β-galactosidase
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reporter gene (lacZ) assay was used as a second cell-fusion assay
[18]. Briefly, NIH3T3 cells were transfected with human CD4 cDNA, a
HIV-1 LTR promoter-driven lacZ gene DNA construct and cDNAs for
TYMSTR or chemokine receptors (CXCR4, CCR5). Vector DNA
(pcDNA3) was used as negative control. Cells were cultured at 1 × 105
cells/well in 24-well plates for 18 h and were then mixed with cloned
HeLa cells that stably expressed viral Tat protein and Env glycoproteins
from HIV-1 Lai or HIV-1 ADA. A HeLa cell clone expressing Tat but
lacking viral Env (∆Env) was used as control. Cells were fixed with
0.5% glutaraldehyde, and cell fusion was visualized by staining for 
β-galactosidase activity.
PCR amplification of proviral DNA
Murine pre-B 300-19 cells (5 × 106 cells/4 ml), stably expressing either
human CD4 or CD4 and TYMSTR were infected for 3 h with 2.5 ml
infectious HIV-1 Lai particles (350 ng/ml HIV-1 p24). After three
washes, the cells were trypsinized, resuspended in fresh medium and
cultured for a further 21 h. As control, the infection was performed in
the presence of SDF-1 (100 nM) or AZT (10 µM) or a combination of
both agents. After extraction of total DNA [43], 30 cycles of PCR were
performed with 32P-labeled primers for proviral DNA (3′-primer, 5′-
CCTGCGTCGAGAGAGCTCCTCTGG-3′; 5′-primer, 5′-GGCTAAC-
TAGGGAACCCACTG-3′) in 25 µl 0.25 mM dNTPs, 50 mM NaCl,
25 mM Tris-HCl, pH 8.0, 5 mM MgCl2, 100 mg/ml BSA and 1.5 U Taq
DNA polymerase (Amersham), yielding amplified DNA of 200 bp. As
control, β-actin DNA (244 bp) was amplified (5′-primer, 5′-GTGGGGC
GCCCCAGGCACCA-3′; 3′-primer, 5′-CGGTTGGCCTTGGGGTTCA
GGGGGG-3′). Amplification products were separated by polyacryl-
amide gel electrophoresis and visualized by autoradiography.
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